Lacosamide 72266-0242-05
- Manufacturer
- Fosun Pharma Usa
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- November 15, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA215628
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 10 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
72266-0242-05Selected5 VIAL, SINGLE-DOSE in 1 CARTON (72266-242-05) / 20 mL in 1 VIAL, SINGLE-DOSE (72266-242-01)